ALZN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alzamend Neuro Inc (ALZN) is not a strong buy for a beginner investor with a long-term focus at this time. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading or sentiment trends. While the technical indicators show some neutral to slightly positive signals, they are insufficient to justify a buy recommendation given the user's investment profile and goals.
The MACD histogram is positive and expanding, indicating a slight bullish momentum. However, the RSI is neutral at 42.575, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near a resistance level (R1: 1.042), which could limit further upward movement.
The MACD shows slight bullish momentum, and the post-market price change of 3.97% indicates some short-term buying interest.
No significant news, hedge fund, or insider trading trends. The financial performance is weak, with negative EPS and net income. The stock's long-term trend is bearish, and there is no recent congress trading data or valuation data to support a buy decision.
In Q3 2026, revenue remains at 0 with no YoY growth. Net income improved YoY but remains negative at -$2,198,991. EPS dropped significantly by -66.86% YoY, and gross margin remains at 0%. Overall, the company shows poor financial health and no growth.
No analyst ratings or price target changes available.
